| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 3.655 | 1.155 | 2.190 | 906 | 5.973 | 26.451 |
| Total Income - EUR | - | - | - | - | 3.655 | 1.155 | 2.190 | 906 | 5.973 | 26.461 |
| Total Expenses - EUR | - | - | - | - | 906 | 560 | 587 | 432 | 1.820 | 3.573 |
| Gross Profit/Loss - EUR | - | - | - | - | 2.749 | 594 | 1.603 | 475 | 4.152 | 22.888 |
| Net Profit/Loss - EUR | - | - | - | - | 2.640 | 561 | 1.538 | 448 | 3.488 | 19.036 |
| Employees | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Hema Transplant S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 0 | 0 | 0 | 0 | 1.195 | 679 |
| Current Assets | - | - | - | - | 3.331 | 2.334 | 3.847 | 4.205 | 7.095 | 20.320 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 0 | 0 | 358 | 0 | 955 | 0 |
| Cash | - | - | - | - | 3.331 | 2.334 | 3.489 | 4.205 | 6.139 | 20.320 |
| Shareholders Funds | - | - | - | - | 2.703 | 2.258 | 3.745 | 4.205 | 7.680 | 19.181 |
| Social Capital | - | - | - | - | 63 | 124 | 121 | 122 | 121 | 121 |
| Debts | - | - | - | - | 628 | 76 | 102 | 0 | 610 | 1.818 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Hema Transplant S.r.l.